Jarrett O - Search Results

1

Limited efficacy of an inactivated feline immunodeficiency virus vaccine.

Dunham SP, Bruce J, MacKay S, Golder M, Jarrett O, Neil JC. Dunham SP, et al. Among authors: jarrett o. Vet Rec. 2006 Apr 22;158(16):561-2. doi: 10.1136/vr.158.16.561. Vet Rec. 2006. PMID: 16632531 Clinical Trial. No abstract available.

2

Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and -18.

Dunham SP, Flynn JN, Rigby MA, Macdonald J, Bruce J, Cannon C, Golder MC, Hanlon L, Harbour DA, Mackay NA, Spibey N, Jarrett O, Neil JC. Dunham SP, et al. Among authors: jarrett o. Vaccine. 2002 Feb 22;20(11-12):1483-96. doi: 10.1016/s0264-410x(01)00507-2. Vaccine. 2002. PMID: 11858854

3

Involvement of cytolytic and non-cytolytic T cells in the control of feline immunodeficiency virus infection.

Flynn JN, Dunham S, Mueller A, Cannon C, Jarrett O. Flynn JN, et al. Among authors: jarrett o. Vet Immunol Immunopathol. 2002 Mar;85(3-4):159-70. doi: 10.1016/s0165-2427(01)00425-1. Vet Immunol Immunopathol. 2002. PMID: 11943317

4

Prime-boost vaccination using DNA and whole inactivated virus vaccines provides limited protection against virulent feline immunodeficiency virus.

Dunham SP, Bruce J, Klein D, Flynn JN, Golder MC, MacDonald S, Jarrett O, Neil JC. Dunham SP, et al. Among authors: jarrett o. Vaccine. 2006 Nov 30;24(49-50):7095-108. doi: 10.1016/j.vaccine.2006.07.001. Epub 2006 Jul 18. Vaccine. 2006. PMID: 17049683

5

Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines.

Hosie MJ, Osborne R, Yamamoto JK, Neil JC, Jarrett O. Hosie MJ, et al. Among authors: jarrett o. J Virol. 1995 Feb;69(2):1253-5. doi: 10.1128/JVI.69.2.1253-1255.1995. J Virol. 1995. PMID: 7815500 Free PMC article.

6

Feline leukemia virus DNA vaccine efficacy is enhanced by coadministration with interleukin-12 (IL-12) and IL-18 expression vectors.

Hanlon L, Argyle D, Bain D, Nicolson L, Dunham S, Golder MC, McDonald M, McGillivray C, Jarrett O, Neil JC, Onions DE. Hanlon L, et al. Among authors: jarrett o. J Virol. 2001 Sep;75(18):8424-33. doi: 10.1128/jvi.75.18.8424-8433.2001. J Virol. 2001. PMID: 11507187 Free PMC article.

7

A recombinant feline immunodeficiency virus envelope fusion protein stimulates peripheral blood lymphocytes from naive cats to proliferate in vitro.

Beatty JA, Reid G, Rigby MA, Neil JC, Jarrett O, Browning MJ. Beatty JA, et al. Among authors: jarrett o. Vet Immunol Immunopathol. 1992 Dec;35(1-2):143-53. doi: 10.1016/0165-2427(92)90127-c. Vet Immunol Immunopathol. 1992. PMID: 1337393

8

Enhancement after feline immunodeficiency virus vaccination.

Hosie MJ, Osborne R, Reid G, Neil JC, Jarrett O. Hosie MJ, et al. Among authors: jarrett o. Vet Immunol Immunopathol. 1992 Dec;35(1-2):191-7. doi: 10.1016/0165-2427(92)90131-9. Vet Immunol Immunopathol. 1992. PMID: 1337397 Free PMC article.

9

Feline immunodeficiency virus as a model for AIDS vaccination.

Jarrett O, Yamamoto JK, Neil JC. Jarrett O, et al. AIDS. 1990;4 Suppl 1:S163-5. AIDS. 1990. PMID: 1967108 Review. No abstract available.

10

Longitudinal analysis of feline leukemia virus-specific cytotoxic T lymphocytes: correlation with recovery from infection.

Flynn JN, Dunham SP, Watson V, Jarrett O. Flynn JN, et al. Among authors: jarrett o. J Virol. 2002 Mar;76(5):2306-15. doi: 10.1128/jvi.76.5.2306-2315.2002. J Virol. 2002. PMID: 11836409 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238 results

Search Page

Filters